Seres Therapeutics
MCRB
MCRB
137 hedge funds and large institutions have $538M invested in Seres Therapeutics in 2023 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 23 reducing their positions, and 22 closing their positions.
Holders
137
Holders Change
+14
Holders Change %
+11.38%
% of All Funds
2.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
59
Reduced
23
Closed
22
Calls
$12.8M
Puts
$4.23M
Net Calls
+$8.6M
Net Calls Change
+$9.37M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NRD
151
Nebula Research & Development
New York
| – | -$67.4K | -595 | Closed |
|
152
Walleye Trading
New York
| – | -$57.8K | -510 | Closed |
|
|
QCG
153
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$11.9K | -105 | Closed |
|
|
OCM
154
Orion Capital Management
Coronado,
California
| – | -$5.67K | -50 | Closed |
|
|
CA
155
Crewe Advisors
Salt Lake City,
Utah
| – | -$3.83K | -34 | Closed |
|
|
S
156
SignatureFD
Atlanta,
Georgia
| – | -$1.92K | -17 | Closed |
|
157
US Bancorp
Minneapolis,
Minnesota
| – | -$992 | -9 | Closed |
|
|
GFWA
158
Grey Fox Wealth Advisors
Rockland,
Delaware
| – | -$567 | -5 | Closed |
|
|
BAM
159
Belpointe Asset Management
Reno,
Nevada
| – | -$278 | -2 | Closed |
|